The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
904409622 9044096 22 F 201101 20160919 20130130 20160928 EXP PHHY2013CA007594 NOVARTIS 60.56 YR F Y 0.00000 20160928 CN COUNTRY NOT SPECIFIED CA

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
904409622 9044096 1 PS GLEEVEC IMATINIB MESYLATE 1 Oral 400 MG, QD 21588 400 MG TABLET QD
904409622 9044096 2 SS GLEEVEC IMATINIB MESYLATE 1 Oral 400 MG, QD 21588 400 MG TABLET QD
904409622 9044096 3 SS GLEEVEC IMATINIB MESYLATE 1 Oral 400 MG, QD 21588 400 MG TABLET QD
904409622 9044096 4 C LOSEC OMEPRAZOLE 1 Unknown UNK 0
904409622 9044096 5 C LOSEC OMEPRAZOLE 1 Unknown UNK 0
904409622 9044096 6 C VITAMIN B12 CYANOCOBALAMIN 1 Unknown UNK UNK, QMO U 0 INJECTION /month
904409622 9044096 7 C APO-OMEPRAZOLE OMEPRAZOLE 1 Unknown 20 MG, UNK Y 0 20 MG
904409622 9044096 8 C APO-HYDROCHLOROTHIAZIDE 2 Unknown Y 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
904409622 9044096 1 Chronic myeloid leukaemia
904409622 9044096 4 Product used for unknown indication
904409622 9044096 6 Product used for unknown indication
904409622 9044096 7 Product used for unknown indication
904409622 9044096 8 Hypertension

Outcome of event

Event ID CASEID OUTC COD
904409622 9044096 HO
904409622 9044096 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
904409622 9044096 Abdominal abscess
904409622 9044096 Abdominal discomfort
904409622 9044096 Abdominal sepsis
904409622 9044096 Blood pressure decreased
904409622 9044096 Blood test abnormal
904409622 9044096 Burning sensation
904409622 9044096 Chills
904409622 9044096 Diarrhoea
904409622 9044096 Diarrhoea haemorrhagic
904409622 9044096 Dysgeusia
904409622 9044096 Dyspnoea
904409622 9044096 Eye swelling
904409622 9044096 Fistula
904409622 9044096 Gastroenteritis viral
904409622 9044096 Genital haemorrhage
904409622 9044096 Haemorrhage
904409622 9044096 Herpes zoster
904409622 9044096 Hot flush
904409622 9044096 Hyperhidrosis
904409622 9044096 Hypersensitivity
904409622 9044096 Infection
904409622 9044096 Influenza
904409622 9044096 Malaise
904409622 9044096 Muscle spasms
904409622 9044096 Nausea
904409622 9044096 Night sweats
904409622 9044096 Paraesthesia
904409622 9044096 Pneumonia
904409622 9044096 Rash generalised
904409622 9044096 Temperature intolerance
904409622 9044096 Vomiting
904409622 9044096 Weight decreased

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
904409622 9044096 1 20101230 201101 0
904409622 9044096 2 201102 0
904409622 9044096 3 201103 0